Dirk Kuyper, Alphatec Spine’s president and CEO, attributed the company’s success to the launch of several new products during the third quarter, including PureGen technologies.
The company reported $30 million in U.S. revenues, an increase of 15.2 percent from the third quarter of 2009. The gross profit for the third quarter was reported as $28.9 million, a 44.1 percent increase over the third quarter of 2009.
Read the release on Alphatec Spine’s 3Q FY 2010 financial report.
Read other coverage on Alphatec Spine:
– Alphatec Spine Signs Agreement With Merlot OrthopediX for Spine Surgery Technology
– Alphatec Spine Receives CE mark of Approval for Spinal Systems
– Alphatec Holdings Names Former Johnson & Johnson CFO as New CFO
